ArticleBMC health services research2025
Investigating use of diagnostic codes for post-COVID- 19 condition in Ontario health administrative data.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn January 2023 the Ontario Health Insurance Plan (OHIP) introduced a diagnostic code for post-COVID-19 condition (PCC). We used this code to estimate the incidence rate of PCC, to compare demographic and clinical characteristics of individuals who received a PCC code to those who didn't, and to investigate healthcare utilization of individuals who received a PCC code.
methodsWe conducted a retrospective cohort study using health administrative data from Ontario, Canada (population approximately 15 million). Individuals who had received a PCC diagnostic code between January 2023 and January 2024 were identified using OHIP, a physician billing database. For the entire population of Ontario, crude incidence rates of PCC were computed and patient characteristics (including age, sex, geographic location, comorbidities, and marginalization index) were collected and compared between individuals who had received a PCC code and those who hadn't using logistic regression models. Healthcare utilization rates for people who received a PCC code were compared pre-pandemic (January 1st, 2017 to March 31st, 2020), pre-PCC (April 1st, 2020 to 24-weeks pre-PCC diagnostic code), and post-PCC (24-weeks pre-PCC diagnostic code to study end).
resultsA PCC code was received by 7,343 individuals. Median age was 62, and 60% were female. When compared to the entire population of Ontario, female sex, older adults, Northern Ontario residents, and comorbid individuals had greater odds of receiving a PCC code. People who were visible minorities, immigrants, and had less access to material resources had lower odds of receiving a PCC code. Healthcare utilization rates, pre-pandemic, pre-PCC, and post-PCC were 14.59 (CI 13.63-15.61), 27.43 (CI 25.01-30.27), and 100.61 (CI 93.39-107.73) encounters per person-year respectively.
conclusionThe number of cases captured was lower than what Health Canada estimates would indicate and it is likely that the code is underrepresenting PCC in Ontario. The substantial increases in healthcare utilization suggests the code is capturing severe PCC cases. The characteristics of the cohort were similar to what has been described in peer-reviewed literature, suggesting that the patients in this cohort have PCC. This code could offer a promising way to study a large diverse population of people with PCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.